Reduction of Proteinuria in a Patient With Primary Aldosteronism by Angiotensin II Receptor Blocker Administration

The renin–angiotensin–aldosterone system (RAAS) is a major target for treating hypertension and preventing various complications. Mineralocorticoid receptor (MR) antagonists are recommended as specific drugs to ameliorate hyperactive MR signaling, especially for patients with idiopathic hyperaldoste...

Descripción completa

Detalles Bibliográficos
Autores principales: Rikitake, Junjiro, Ashida, Kenji, Miura, Mami, Nomura, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578373/
https://www.ncbi.nlm.nih.gov/pubmed/37908267
http://dx.doi.org/10.1210/jcemcr/luac021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578373/
https://www.ncbi.nlm.nih.gov/pubmed/37908267
http://dx.doi.org/10.1210/jcemcr/luac021

Ejemplares similares